Industry News's blog

DMCA.com Protection Status
Industry News's picture

June 27, 2019 – The Wound Healing Foundation, through the support of Medline Corius Tissue Regeneration, announces the call for proposals for the second of three one year grant series; WHF-Medline Research Grant Innovation Award. This $30,000 grant award for the best scientific and innovative proposal will be awarded May 2020 in San Diego, California.

Blog Category: 
Industry News's picture

McDonough, GA, June 23, 2019 – Encompass Group, LLC premiered its transformative new Airisana™ Therapeutic Support Surface in its exhibit booth at the WOCNext 2019 Conference in Nashville, Tennessee. Airisana™ is a unique, never-before-seen approach to pressure management therapy and microclimate. By combining all of the best practices devised to reduce health care-acquired pressure injuries into one surface and control unit, it replaces up to five other surface types.

Blog Category: 
Industry News's picture

By KCI, an Acelity Company

San Antonio, TX, – May 21, 2019 – KCI, an Acelity Company, announces that the Company has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for DERMATAC™ Drape, a proprietary silicone-acrylic hybrid drape that provides both clinical and operational benefits, as an accessory to certain of KCI’s Negative Pressure Wound Therapy (NPWT) Systems. Constructed with a precise combination of silicone and acrylic, DERMATAC™ Drape conforms to different anatomical locations, adapting to the body and providing a tight, highly effective seal for 48 to 72 hours, including uneven areas, for wound protection, creating the ideal balance for wound healing support.

Industry News's picture

Huntington, WV – May 21, 2019 – DARCO International announces the latest addition to their line of products, the DUO Med Surg Shoe.

Blog Category: 
Industry News's picture
Keywords: 

By AristaMD

Savannah, GA – May 15, 2019 – AristaMD, an innovative telehealth platform that delivers timely, documented access to specialist insight through eConsults, partners with Corstrata, a provider of digital health care IT solutions and services for wound prevention and care management, to add board-certified wound and ostomy specialists to its already extensive specialist panel. Due to high client demand, AristaMD’s initiative to partner with Corstrata will ensure its eConsult platform continues to offer the most comprehensive access to specialty care. AristaMD’s wound and ostomy panel is set to launch May 14th.

Blog Category: 
Industry News's picture

By PolarityTE®

Salt Lake City – May 10, 2019 – PolarityTE, Inc., a biotechnology company developing and commercializing regenerative tissue products and biomaterials, announced today data from two pilot studies on the use of its SkinTE™ product both showing successful closure of diabetic foot ulcers (DFUs) and venous stasis leg ulcers (VLUs) within a 12-week period. The cases involved patients with lower extremity chronic wounds that were difficult to treat or had failed to heal with standard dressing care and conventional treatments, using a single application of SkinTE.

Blog Category: 
Industry News's picture
Keywords: 

by PolarityTE®

Salt Lake City – April 24, 2019 – PolarityTE®, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, announced today that new clinical data on the use of its SkinTE™ product will be presented at the Symposium on Advanced Wound Care (SAWC) Spring, Wound Healing Society meeting in San Antonio, TX from May 7 – 11, 2019. In addition, PolarityTE® will host a booth and an interactive event featuring patients treated with SkinTE™ and a presentation from Dr. Gerhard S. Mundinger, MD, Division of Plastic Surgery, Louisiana State University Health Sciences Center, an early adopter of SkinTE™, on his clinical experience with the product.

Blog Category: 
Industry News's picture

By the National Pressure Ulcer Advisory Panel

Washington, DC. – April 18, 2019 – On April 9, 2019, Dr. William Padula, NPUAP Treasurer, and Dr. Janet Luddigan, NPUAP President, provided written testimony to the House Committee on Appropriations; Subcommittee on Labor, Health and Human Services, Education and Related Agencies to explore new payment models that could further increase innovation and incentivize the prevention or pressure injuries.

Blog Category: 
Industry News's picture

by the National Pressure Ulcer Advisory Panel

Washington, DC – April 12, 2019 – On March 25-27, Dr. William Padula visited Washington, D.C. to advocate for policy solutions surrounding pressure injury prevention at the highest levels of government and health care. His independent advocacy for improving patient safety was provided as a researcher on behalf of NPUAP and its panel members. Dr. Padula is Treasurer on the Board of Directors for NPUAP, as well as an Assistant Professor of Health Economics at the University of Southern California Schaeffer Center for Health Policy & Economics in Los Angeles, along with a secondary appointment at the Johns Hopkins School of Nursing in Baltimore.

Blog Category: 
Industry News's picture

by Jennifer Hurlow, GNP, CWOCN, and Kara Couch, MS, CRNP, CWCN-AP

Chronic wounds are increasingly recognized as a global public health issue. Recent research revealed that nearly 15% of Medicare beneficiaries (>65 years of age) had at least one type of chronic wound in 2014. In the United States, there are an estimated 6.5 million chronic wounds, including leg ulcers, pressure ulcers, and diabetic foot ulcers, each of which carries a mean annual treatment cost of $11,000, $15,400, and $42,100, respectively, leading to an economic burden of $96.8 billion dollars for the treatment of chronic wounds. Prevalence of chronic wounds is estimated to be growing at a rate of 13% per year, further adding to this current problem. Wound chronicity has been directly related to the presence of wound biofilm. Costerton and colleagues were the first to link biofilm with general infection risk.

Blog Category: 

Important Notice: The contents of the website such as text, graphics, images, and other materials contained on the website ("Content") are for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. The content is not intended to substitute manufacturer instructions. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or product usage. Refer to the Legal Notice for express terms of use.